We've found
10,154
archived clinical trials in
Other Indications
We've found
10,154
archived clinical trials in
Other Indications
Cosmetic Outcomes and Patient Satisfaction After Facial Laceration Repair in the Emergency Department
Status: Enrolling
Updated: 7/30/2013
Updated: 7/30/2013
Cosmetic Outcomes and Patient Satisfaction After Facial Laceration Repair in the Emergency Department
Status: Enrolling
Updated: 7/30/2013
Updated: 7/30/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Updated: 8/2/2013
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Vitamin D in Vulnerable Adults (VIVA-VA)
Updated: 8/2/2013
Vitamin D in Vulnerable Adults
Status: Enrolling
Updated: 8/2/2013
Vitamin D in Vulnerable Adults (VIVA-VA)
Updated: 8/2/2013
Vitamin D in Vulnerable Adults
Status: Enrolling
Updated: 8/2/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 8/9/2013
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
A Study of RG1662 in Individuals With Down Syndrome
Updated: 9/9/2013
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Updated: 9/13/2013
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Updated: 9/25/2013
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Click here to add this to my saved trials